Atlas Trials

Efficacy/Safety of HCP1306 Tablet Versus HGP0816 Tablet in Patients With Primary Hypercholesterolemia

Clinical trial NCT02205606 · COMPLETED

Trial details

NCT number
NCT02205606
Sponsor
Hanmi Pharmaceutical Company Limited
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Primary Hypercholesterolemia
Start date
2014-06-01
Primary completion
2015-02-01
Enrollment
412

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.